致病性BRCA1突变破坏了BARD1的全控制
Ayan Bhattacharjee1, Gregory R Bowman1
1Departments of Biochemistry & Biophysics and Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, United States.
bioRxiv : the preprint server for biology
|July 15, 2025
概括
致病性BRCA1突变通过破坏其活性状态来破坏与癌症相关的E3酶活性. 了解BARD1结合如何选择活跃的BRCA1形状,为开发新疗法提供了战略.
科学领域:
- 生物物理学的生物物理.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在BRCA1的致病性误解突变与遗传性乳腺和卵巢癌有关.
- 这些突变破坏BRCA1的E3酶活性并导致瘤发生的确切机制尚不清楚.
- 通过结合BARD1.1来激活BRCA1的E3结合酶活性.
研究的目的:
- 阐明巴德1结合激活BRCA1的E3结合酶活性的机制.
- 研究BRCA1中的病原性突变如何影响其构造状态和E3酶活性.
- 确定恢复BRCA1功能的潜在治疗策略.
主要方法:
- 原子学分子动力学模拟.
- 马尔科夫状态建模.
- 整体合分析. 合分析.
主要成果:
- BARD1结合选择了BRCA1.1的活性构造状态.
- BARD1的结合部位 (螺旋捆) 与E2接口结合.
- 病原性突变会破坏这些活跃状态的稳定,而过度活跃的突变会增加它们的可能性.
结论:
- BRCA1 病原体与 BARD1 介导的活跃构造状态的选择有关.
- 病原性突变破坏了这一过程,通过异性地破坏活性状态来破坏这种过程.
- 这些发现为设计用于恢复BRCA1功能的小分子疗法提供了机制基础.
更多相关视频
相关概念视频
Restarting Stalled Replication Forks
5.9K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Long-patch Base Excision Repair
7.2K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.2K


